Protea Biosciences Group Inc

Common Stock SEC Reporting - Current
Contact Info
  • 1311 Pineview Drive
  • Suite 501
  • Morgantown, WV 26505

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001335103
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Sep 30, 2013
Incorporated In: DE, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts
Stephen Turner CEO, President
Matthew Powell CSO
Cynthia Price Finance Manager
Greg Kilby Consultant
Company Directors
Stephen Turner Chairman
Steven Antoline
Josiah Austin
Leonard Harris
Stanley Hostler
Roderick Jackson
Ed Roberson
Scott Segal
Service Providers
Accounting/Auditing Firm
Malin, Bergquist & Company, LLP
3605 McKnight East Drive
Pittsburgh, PA, 15237
United States

Schneider Downs & Co., Inc.
One PP Place
Suite 1700
Suite 1700, PA, 15222
United States

Schneider Downs & Co., Inc.
One PPG Place
Suite 1700
Pittsburgh, PA, 15222
United States

Legal Counsel
1330 Avenue of the Americas
35th Floor
New York, NY, 10019
United States

Investor Relations Firm
ProActive Capital Resources Group, LLC
641 Lexington Ave
Suite 618
New York, NY, 10022
United States

PRGB Security Details
Share Structure
Market Value1 $18,052,270 a/o Oct 24, 2016
Authorized Shares 250,000,000 a/o Mar 22, 2016
Outstanding Shares 133,720,519 a/o Aug 15, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,679,540 a/o Mar 22, 2016
Par Value 0.0001
Transfer Agent(s)
Island Stock Transfer
Shareholders of Record 519 a/o Mar 22, 2016
Short Selling Data
Short Interest 8,569 (39.77%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security